With sparse guidance regarding best practices for IHC in melanoma diagnosis, more research is needed to optimize use of IHC in this setting, according to the authors.
A Finnish study shows that adding polygenic risk scores to positive family histories and breast cancer-associated gene mutations improves risk stratification for breast cancer screening.